country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-187622

Copy Link Print Information

Org 33201

Org 33201 is an orally active and selective Aromatase inhibitor with an IC₅₀ of 2.2 nM. Org 33201 inhibits the activity of Aromatase by binding to its heme iron. Org 33201 can be used in the study of estrogen-dependent diseases (such as postmenopausal breast cancer).

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

CAS No.: 148714-92-5
Formule: C₂₁H₂₉ClN₂S
Masse moléculaire:376.99

Stockage:

Please store the product under the recommended conditions in the Certificate of Analysis.

Org 33201 Chemical Structure

CAS No.: 148714-92-5

Stock

Quantité

Amount: USD 0.00

* Veuillez sélectionner la quantité avant d'ajouter des articles.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Activité biologique
- Description
- IC₅₀ & Target
- In Vitro
- In Vivo
Chemical Information
Pureté et documentation
Références
Calculators
Help & FAQs
Classifications
Bioz

Activité biologique

Description

IC₅₀ & Target

^[1]

Aromatase

2.2 nM (IC₅₀)

Voir tous les produits spécifiques à Isoform Cytochrome P450 :

In Vitro

Org 33201 potently inhibits aromatase activity in human placental microsomes, with an IC₅₀ of 2.2 nM, and acts as a competitive inhibitor by binding to heme iron^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Org 33201 (0.5-1 mg/kg; p.o.; single dose) reduces plasma estradiol levels in a dose-dependent manner in beagle dogs treated with FSH (HY-NP197)/hCG (HY-107953)^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Related Protocols :

Chemical Information

CAS No. 148714-92-5
Masse moléculaire 376.99
Formule C₂₁H₂₉ClN₂S
SMILES

C(C)[C@@]12C=3C(=C(SCC)C=CC3CCC1)C[C@@H](CN4C=CN=C4)C2.Cl
Livraison

Room temperature in continental US; may vary elsewhere.
Stockage

Please store the product under the recommended conditions in the Certificate of Analysis.

Pureté et documentation

Instruction de manipulation (2659 KB)

Références

[1]. Kui Lin, et al. Treatment of breast cancer using combination therapies comprising an ATP competitive AKT inhibitor, a CDK4/6 inhibitor, and fulvestrant. WO2021030248A1. WIPO. 2021-02-18.

[2]. Vanden Bossche HV, et al. Aromatase inhibitors--mechanisms for non-steroidal inhibitors. Breast cancer research and treatment. 1994;30(1):43-55.

Calculators

Calculateur de molarité

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Calculateur de dilution

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Obtenir un devis En stock

Other size

Obtenir un devis